# Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

> **NCT01492127** · NA · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 64 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Cirrhosis

## Interventions

- **BIOLOGICAL:** Blood test

## Key facts

- **NCT ID:** NCT01492127
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2014-03
- **Final completion:** 2016-03
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2015-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01492127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01492127, "Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01492127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*